{"anticipatedPostingDate":"2027-12","denomUnitsSelected":"Participants","description":"DOR: time from first documentation of confirmed CR/PR to first documentation of PD according to RECIST v1.1 or death from any cause, whichever occurred earlier. Per RECIST v1.1, CR: disappearance of all T/NT lesions(L). Any pathological lymph nodes (whether T/NT) must have reduction in short axis to \\<10 mm. PR: at least \\>=30 % decrease in SOD of TL, taking reference baseline sum diameters. PD: at least \\>=20% relative increase in SOD of TL taking reference smallest sum on study. Participants who do not have PD \\& were still on study at time of an analysis/ who have started new anticancer treatment/discontinue prior to documentation of PD were censored at date of last adequate response assessment documenting absence of PD. Participants who had PD/death occurred after two/more consecutive missing scheduled response assessments were censored at date of last adequate response assessment of CR, PR, SD,/non-CR/non-PD. Kaplan-Meier method was used for evaluation.","reportingStatus":"NOT_POSTED","timeFrame":"From the first documented CR or PR until the first documentation of PD or death or censoring date, whichever occurred first (approximately 52.7 months)","title":"Duration of Response (DOR) as Assessed by Investigator","type":"SECONDARY"}